drugset / Trial / NCT03783910

Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia

NCT03783910 ↗

Phase 2 Completed 90 enrolled Grünenthal GmbH
RandomizedCrossoverQuadruple-blindTreatment

Summary

The study was performed in participants suffering from fibromyalgia and investigated efficacy after treatment with several doses of GRT9906 versus placebo. Furthermore, it was to be found out if treatment with GRT9906 was safe and well-tolerated.

Timeline

Start
2005-09-19
Primary completion
2006-10
Completion
2006-10-20

Drugs

EvaluationDrugModalityDoseRoute
Subject GRT9906 Unknown 80 mg Oral
Subject GRT9906 Unknown 240 mg Oral

Indications